Dr Ritu Gupta is Professor and Officer In-Charge of Laboratory Oncology Unitat the AIIMS New Delhi and Laboratory services at National Cancer Institute, Jhajhar. She is a Lead assessor for National Accreditation Board for testing & calibration laboratories (NABL), an active task force member and reviewer for Department of Biotechnology (DBT), Indian Council Medical Research (ICMR), Department of Science and Technology (DST) and technology Development Board (TDB), India, National Science Center (Poland). She is also Vice-President of The Cytometry Society (TCS), India. She is member secretary of laboratory advisory committee at the National Cancer Institute (NCI), India. She is a member of the Central Core Research Facility (CCRF) committee of AIIMS and has contributed particularly in the development of the Genomics and Flow cytometry facilities of the CCRF.
Prof. Gupta leads as the Principal investigator of Unit of Excellence on Multiple Myeloma and Centre of Advanced Research & Education on Acute Myeloid Leukemia. Her major research interests pertain to translational research in hematological malignancies. Her laboratory has pioneered several major findings of clinical importance in hemato-oncology in India. Her most remarkable achievements during the last few years include establishment of several hematological investigations of clinical relevance in hematolymphoid malignancies as well setting up laboratory protocols for state of art technologies for research purpose. On the clinical front, she has established protocols for minimal residual disease estimation in hematolymphoid malignancies and published papers especially on multiple myeloma; established IGHV somatic mutation detection and ZAP70 assay for evaluation of patients with CLL and; copy number variation detection in hematolymphoid malignancies. Few of the research strategies established include protocols for evaluation of Treg and TH17 cells, rare event analysis for enumeration of stem cells and circulating endothelial progenitor cells. Considering the challenges in detecting low levels of residual malignant cells, her laboratory is working in collaboration with leading technical institutes of the country to develop image processing modules to address minimal residual disease detection.
Dr Gupta has obtained her MBBS from University of Rajasthan, India and MD from Manipal Academy of Higher Education, India. She acquired certification of DNB from National Board of Examination, New Delhi the same year followed by specialist tranining in Hemato-Oncopathology at Laboratory Oncology, AIIMS. She worked as Assistant Professor at Sanjay Gandhi Post graduate Institute of Medical Sciences and established diagnostic laboratories in the newly created Department of Hematology. Later, she returned to Laboratory Oncology Unit at the AIIMS and is currently Professor and Officer In-Charge of this unit.